Integrated use of genomics, metabolomics, and cytokine profiling to validate the use of 'dirty' mice to study sepsis pathophysiology

综合使用基因组学、代谢组学和细胞因子分析来验证使用“脏”小鼠研究脓毒症病理生理学

基本信息

  • 批准号:
    10257687
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-10-01 至 2023-09-30
  • 项目状态:
    已结题

项目摘要

Each year ~2 million adult Americans develop sepsis and nearly 270,000 Americans die as a result of sepsis. In the U.S. VA health system in 2009, >35,000 Veterans were hospitalized with sepsis, and ~80% survived to hospital discharge (current numbers are likely higher). Veterans also have a high rate of hospital readmission following sepsis. Hospital costs associated with treating sepsis exceed $24B/year, making it the most expensive medical condition treated in the U.S. Faced with costly and burdensome patient care, it is imperative to better understand the pathophysiologic states experienced by these patients to deliver targeted care. Mice are one of the most important tools used in biomedical research, due in part to their ability to model complex physiological systems in humans. However, environmental microbial exposure is an important difference between basic human and laboratory mouse biology that must be considered when using mouse models to evaluate immune system fitness. Humans are naturally exposed to both commensal and pathogenic microbes daily from birth, and the immune system of adult humans has been trained and shaped by each microbe. In contrast, laboratory mice are often housed under specific pathogen-free (SPF) conditions. SPF housing has been instrumental in increasing experimental reproducibility, but it has simultaneously further distanced the mouse model from humans, largely because SPF mice live their lives with limited microbial exposure. Our proposal will leverage a novel mouse model that mimics critical aspects of the human immune system – where exposure to multiple ongoing and resolved infections is the norm. We will integrate transcriptomics, metabolomics, proteomics, and cytokine profiling to define the molecular basis of the pathophysiology and resolution of sepsis. The proposed validation studies will be key for supporting the use of microbially-experienced ‘dirty’ mice in sepsis research. There are no reported direct comparisons of immune responses in dirty septic mice to human patients. We posit that direct comparison of acute response in septic patients to sepsis models in dirty mice will show a closer correlation than the comparison between human and SPF mice. It has been argued that rodent models do not resemble the pathophysiology of human sepsis, an assumption boosted by studies claiming the molecular changes observed in human sepsis are different from the ones observed in rodents. Yet, the rodent system is an invaluable tool to advance current understanding of the immune system that will produce important information to understand septic pathology and provide clues for seeking ways to ameliorate the conditions. The main concern raised about dirty mice is the potential of increased variability in the commensal and pathogenic microbes they have encountered. If one intention of new mouse models for biomedical research is to better model humans with a diverse microbial experience, then using mice with a similarly diverse microbial exposure history must be viewed as a strength. It is important to emphasize dirty mice are meant to serve as a novel complement to, rather than replace, the SPF mice typically used in sepsis research. We see dirty mice as a valuable tool for discovering new efficacious sepsis therapies that may be sensitive to the environmental perturbations after microbial exposure.
每年约有200万成年美国人患上败血症,近27万美国人死于败血症。 2009年,在美国退伍军人管理局卫生系统中,超过35,000名退伍军人因败血症住院,约80%的人存活至 出院(目前的数字可能更高)。退伍军人的再入院率也很高 脓毒症之后与治疗脓毒症相关的医院费用超过240亿美元/年,使其成为最 面对昂贵而繁重的病人护理, 以更好地了解这些患者所经历的病理生理状态,从而提供有针对性的护理。小鼠 是生物医学研究中最重要的工具之一,部分原因是它们能够模拟复杂的 人体的生理系统。然而,环境微生物暴露是一个重要的区别 在使用小鼠模型时必须考虑的基本人类和实验室小鼠生物学之间的差异, 评估免疫系统的适应性人类自然地暴露于肠道和病原微生物 每种微生物从出生起每天都在生长,成年人的免疫系统也是由每种微生物训练和塑造的。在 相比之下,实验室小鼠通常被饲养在无特定病原体(SPF)的条件下。SPF住房具有 有助于提高实验的可重复性,但同时也进一步疏远了 来自人类的小鼠模型,主要是因为SPF小鼠一生中接触的微生物有限。我们 该提案将利用一种新型的小鼠模型,该模型模拟了人类免疫系统的关键方面, 暴露于多个正在进行和已解决的感染是常态。我们将整合转录组学, 代谢组学、蛋白质组学和细胞因子谱分析,以确定病理生理学的分子基础, 脓毒症消退。 拟议的验证研究将是支持使用微生物经验丰富的“脏”小鼠的关键, 败血症研究。目前还没有关于脏脓毒症小鼠与人类免疫反应的直接比较的报道 患者我们认为,直接比较脓毒症患者的急性反应与脏鼠脓毒症模型, 显示出比人类和SPF小鼠之间的比较更密切的相关性。有人认为啮齿动物 模型不类似于人类败血症的病理生理学,这一假设得到了声称 在人脓毒症中观察到的分子变化不同于在啮齿动物中观察到的分子变化。然而, 系统是一个宝贵的工具,以促进目前的理解免疫系统,将产生 重要的信息,了解脓毒症病理学,并提供线索,寻求方法,以改善 条件关于脏老鼠的主要担忧是, 以及他们遇到的致病微生物。如果一个新的小鼠模型用于生物医学的意图 研究是为了更好地模拟具有不同微生物经历的人类,然后使用具有类似微生物经历的小鼠。 不同的微生物暴露史必须被视为一种优势。重要的是要强调脏老鼠是 这意味着作为一种新的补充,而不是取代,SPF小鼠通常用于脓毒症研究。 我们认为脏小鼠是发现新的有效脓毒症疗法的有价值的工具, 微生物暴露后的环境扰动。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Thomas S Griffith其他文献

Apoptosis-inducing Ligand Cell-mediated Delivery of Tumor Necrosis Factor-related Induction of Glioblastoma Apoptosis Using Neural Stem Updated Version Cited Articles Citing Articles E-mail Alerts Induction of Glioblastoma Apoptosis Using Neural Stem Cell-mediated Delivery of Tumor Necrosis Factor-r
细胞凋亡诱导配体 细胞介导的肿瘤坏死因子相关传递 使用神经干诱导胶质母细胞瘤细胞凋亡 更新版本 被引文章 引用文章 电子邮件提醒 使用神经干细胞介导的肿瘤坏死因子-r 诱导胶质母细胞瘤凋亡
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Moneeb Ehtesham;P. Kabos;M. Gutierrez;N. Chung;Thomas S Griffith;Keith L. Black;John S. Yu
  • 通讯作者:
    John S. Yu
EARLY MICRORECANALIZATION OF VAS DEFERENS AFTER IMPLANTATION OF BIODEGRADABLE GRAFTS IN RATS THAT PREVIOUSLY UNDERWENT BILATERAL VASECTOMY
  • DOI:
    10.1016/s0022-5347(08)61866-2
  • 发表时间:
    2008-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Christopher M Simons;Barry R De Young;Thomas S Griffith;Timothy L Ratliff;Surya K Mallapragada;Moshe Wald
  • 通讯作者:
    Moshe Wald
ACTIVATION OF TUMOR-SPECIFIC CD8+ T CELLS AFTER INTRATUMORAL Ad5-TRAIL/CpG ODN COMBINATION THERAPY
  • DOI:
    10.1016/s0022-5347(08)60117-2
  • 发表时间:
    2008-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Rebecca L VanOosten;Thomas S Griffith
  • 通讯作者:
    Thomas S Griffith
PHASE I TRIAL OF Ad5-TRAIL-MEDIATED GENE TRANSFER IN MEN WITH LOCALLY-CONFINED PROSTATE CANCER PRIOR TO PLANNED RADICAL PROSTATECTOMY
  • DOI:
    10.1016/s0022-5347(08)61160-x
  • 发表时间:
    2008-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Thomas S Griffith;Badrinath R Konety;Fadi N Joudi;Tammy Madsen;Barbara Ziegler;Michael B Cohen;Timothy L Ratliff;Richard D Williams
  • 通讯作者:
    Richard D Williams

Thomas S Griffith的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Thomas S Griffith', 18)}}的其他基金

BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
  • 批准号:
    10582394
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
CD4 T cell dysfunction and reprogramming during sepsis
脓毒症期间 CD4 T 细胞功能障碍和重编程
  • 批准号:
    10633073
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Exploiting microbial exposure to study the immune response to uropathogenic E. coli
利用微生物暴露研究对尿路致病性大肠杆菌的免疫反应
  • 批准号:
    10413143
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Integrated use of genomics, metabolomics, and cytokine profiling to validate the use of 'dirty' mice to study sepsis pathophysiology
综合使用基因组学、代谢组学和细胞因子分析来验证使用“脏”小鼠研究脓毒症病理生理学
  • 批准号:
    10512750
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Exploiting microbial exposure to study the immune response to uropathogenic E. coli
利用微生物暴露研究对尿路致病性大肠杆菌的免疫反应
  • 批准号:
    10237569
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
CD4 T cell dysfunction and reprogramming during sepsis
脓毒症期间 CD4 T 细胞功能障碍和重编程
  • 批准号:
    10400169
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Alterations in CD4 T cells during sepsis
脓毒症期间 CD4 T 细胞的变化
  • 批准号:
    9101373
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Impairment and recovery of CD4 T cell-dependent B cell responses after sepsis
脓毒症后 CD4 T 细胞依赖性 B 细胞反应的受损和恢复
  • 批准号:
    10084212
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
Suppression of T cell immunity during sepsis
败血症期间 T 细胞免疫的抑制
  • 批准号:
    8601255
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
Suppression of T cell immunity during sepsis
败血症期间 T 细胞免疫的抑制
  • 批准号:
    8237299
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了